-
Colibri is committed to developing disruptive next generation structural heart technologies that address patient and market needs. Colibri’s advanced technology is a culmination of over 15 years of research and development into “dry” tissue, heart valve design, and delivery system technology.
The Company’s unique tissue processing method produces extremely strong, durable, and biocompatible tissue that enables the only pre-mounted, pre-crimped, and pre-loaded heart valve, making in-procedure valve rinsing, mounting, and loading at time of use unnecessary.
-